Sign up to save your podcasts
Or
Share Principles and Practice Strategies for Immunotherapy in Genitourinary Malignancies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Principles and Practice Strategies for Immunotherapy in Genitourinary Malignancies
CME credits: 1.00
Valid until: 01-11-2023
Claim your CME credit at https://reachmd.com/programs/cme/principles-and-practice-strategies-immunotherapy-genitourinary-malignancies/12033/
Advances in immune checkpoint inhibitor therapy are transforming the way clinicians treat and manage metastatic UC and RCC. Given the approval of immune checkpoint inhibitors for the treatment of metastatic UC and RCC in recent years, and more emerging evidence, it can be challenging to understand how to best incorporate these therapies into current treatment strategies.
This activity will review the latest clinical advances, emerging data, and guideline recommendations for immunotherapy for the treatment of advanced renal cell carcinoma and urothelial carcinoma.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 1.00
Valid until: 01-11-2023
Claim your CME credit at https://reachmd.com/programs/cme/principles-and-practice-strategies-immunotherapy-genitourinary-malignancies/12033/
Advances in immune checkpoint inhibitor therapy are transforming the way clinicians treat and manage metastatic UC and RCC. Given the approval of immune checkpoint inhibitors for the treatment of metastatic UC and RCC in recent years, and more emerging evidence, it can be challenging to understand how to best incorporate these therapies into current treatment strategies.
This activity will review the latest clinical advances, emerging data, and guideline recommendations for immunotherapy for the treatment of advanced renal cell carcinoma and urothelial carcinoma.
=